Pharma-Bio Serv, Inc. Reports Q3 2026 Results

What Happened
On September 14, 2026, Pharma-Bio Serv, Inc. announced its results of operations for the quarter ended July 31, 2026 and furnished the related press release as Exhibit 99.1 to a Form 8-K (Item 2.02). The filing notifies investors that the company has publicly released its quarterly results; the press release itself contains the financial details.

Key Details

• Filed Form 8-K dated September 14, 2026 under Item 2.02 (Results of Operations and Financial Condition).
• The quarterly results cover the period ended July 31, 2026.
• The company furnished a press release (Exhibit 99.1) announcing the results.
• The filing also includes the interactive XBRL cover page (Inline XBRL).

Why It Matters
This filing signals that Pharma-Bio Serv has released its quarterly earnings information — key data points like revenue, net income, margins, and any management commentary will be in the press release. Retail investors should read the attached press release for the specific financial results and any forward-looking commentary, as those figures can affect the company’s stock performance and near-term outlook.